Selective inhibition of PKCα/β, Chk1, and PDK1 promotes tumor cell death, while prednisone alleviates UCN‐01‐related inflammatory responses through immune regulation and enhances targeting of lymphoid tumors. This evidence concerns the gene CHEK1 and lymphoid neoplasm.